Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Uterine Cervical Neoplasms 2Advanced Solid Tumours 2Vaginal Neoplasms 1Tongue Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Previously Treated Non Small Cell Lung Cancer 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Carcinoma, Endometrioid 1Blast Crisis 1Advanced Solid Tumors 1

Interventions

pegfilgrastim 1adavosertib 1Antimitotic Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Previously Treated Non Small Cell Lung Cancer × adavosertib × Clear all
NCT02087176 2016-06-14

A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer

AstraZeneca

Phase 2 Terminated
48 enrolled 11 charts
Thoracic

Previously Treated Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡